Tamoxifen: Too Much of a Good Thing?-Reference-Cited by-同舟云学术

Tamoxifen: Too Much of a Good Thing?

Published:1999-09 Issue:9 Volume:17 Page:2629-2629
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Jordan V. Craig¹

Affiliation:

1. Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.1999.17.9.2629

Reference15 articles.

1. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2. Lerner LJ, Jordan VC: Development of antiestrogens and their use in breast cancer (Eighth BF Cain Memorial Award Lecture). Cancer Res 50:4177,1990-4189,

3. A current view of tamoxifen for the treatment and prevention of breast cancer

4. Hormonal Pathogenesis of Adenocarcinoma of the Breast

5. Jensen EV, Jacobson HI: Basic guide to the mechanism of estrogen action. Recent Prog Horm Res 18:387,1962-414,

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells;Oncotarget;2015-11-06

2. Tamoxifen as a new therapeutic tool for neutrophilic lung inflammation;Respirology;2015-10-29

3. An α-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen;British Journal of Cancer;2007-07-17

4. Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications;The Journal of Steroid Biochemistry and Molecular Biology;2006-12

5. The Italian Breast Cancer Prevention Trial with Tamoxifen;Annals of the New York Academy of Sciences;2006-01-25